z-logo
open-access-imgOpen Access
Cost Minimization Analysis (CMA) of XELOX versus MFOLFOX6 in the treatment of colorectal cancer in a public hospital in Brazil
Author(s) -
Márcia Regina Godoy,
Sara Boscato,
Isabela Heineck
Publication year - 2023
Publication title -
jornal de assistência farmacêutica e farmacoeconomia
Language(s) - English
Resource type - Journals
ISSN - 2525-7323
DOI - 10.22563/2525-7323.2018.v3.s1.p.34
Subject(s) - medicine , folfox , colorectal cancer , activity based costing , checklist , public hospital , randomized controlled trial , oxaliplatin , economic evaluation , family medicine , cancer , nursing , business , psychology , pathology , marketing , cognitive psychology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here